個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Daiichi Sankyo's Acquisition of Ranbaxy - Cultural Issues in Integrating Business Models and Organisations
內容大綱
Daiichi Sankyo was the first major Japanese pharmaceutical firm to acquire a generic drug company. In early 2008, it acquired a majority share in Ranbaxy, then the largest India-based generic drug manufacturer and exporter. This case examines the cross cultural challenges in the post-acquisition task of integration.